February 2015

NV5 Completes Redemption of Outstanding Public WarrantsCNNMoneyThe redemption date for the public warrants was February 5, 2015. Each public warrant entitled the holder to purchase one share of the Company’s common stock at an exercise price of $7.80 per share. The redemption resulted in 408,412, or approximately … and more …read more

NV5 Completes Redemption of Outstanding Public WarrantsMarketWatchThe redemption date for the public warrants was February 5, 2015. Each public warrant entitled the holder to purchase one share of the Company’s common stock at an exercise price of $7.80 per share. The redemption resulted in 408,412, or approximately … and more …read more

BIND Therapeutics Prices Public Offering of Common Stock and Warrants to …MarketWatchEach unit consists of one share of common stock and six-tenths (0.6) of a warrant to purchase one share of common stock with an exercise price of $6.60 per share. All units in the offering are to be sold by BIND. The gross proceeds

BIND Therapeutics Announces Proposed Public Offering of Common Stock and …MarketWatch… developing targeted and programmable therapeutics called Accurins™, today announced that it is commencing an underwritten public offering of units consisting of shares of BIND’s common stock and warrants to purchase shares of BIND’s common stock. and more …read more

BIND Therapeutics Announces Proposed Public Offering of Common Stock and …Business Wire (press release)… developing targeted and programmable therapeutics called Accurins™, today announced that it is commencing an underwritten public offering of units consisting of shares of BIND’s common stock and warrants to purchase shares of BIND’s common stock. and more …read more